Robert Goldberg
Gastroenterology · Miami Beach, FLNPI 1134169196
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2019 at $1,637 and has fallen 95.2% since, to $78 in 2024.
Across 250 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$825
- Johnson & Johnson$546
- Boston Scientific$445
- Takeda Pharmaceuticals U.S.A., Inc.$309
- Redhill Biopharma Inc.$266
- plus $1K from 17 others
What the payments were for
- Food & beverage$5,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $1,371 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 61 | $825 |
| Johnson & Johnson | 24 | $546 |
| Boston Scientific | 10 | $445 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $309 |
| Redhill Biopharma Inc. | 20 | $266 |
| Ironwood Pharmaceuticals, Inc | 9 | $226 |
| Ardelyx, Inc. | 5 | $211 |
| Gilead | 7 | $163 |
| Olympus America Inc. | 3 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $107 |
| Shire North American Group Inc | 4 | $74 |
| Sanofi | 3 | $73 |
| Apollo Endosurgery US Inc | 1 | $47 |
| Braintree Laboratories, Inc. | 3 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| Vivus LLC | 2 | $35 |
| QOL Medical, LLC | 2 | $34 |
| Alfasigma USA, Inc. | 2 | $31 |
| GE HealthCare | 1 | $28 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Novo Nordisk | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBSRELA$146
- EXALT Model D$128
- HABIB ENDOHPB$113
- DUPIXENT$107
How this compares
$5,056 in reported general payments places this provider in the 65th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Miami Beach
- Arin NewmanMiami Beach$716K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.